• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证两种用于预测胃癌根治术后复发和生存的预后模型。

Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.

机构信息

Division of General and Upper Gastrointestinal Surgery, Department of Surgery, University of Verona, Verona, Italy.

Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

出版信息

Br J Surg. 2017 Aug;104(9):1235-1243. doi: 10.1002/bjs.10551. Epub 2017 May 10.

DOI:10.1002/bjs.10551
PMID:28489249
Abstract

BACKGROUND

Prognostic models from Korea and Italy have been developed that predict overall survival and cancer recurrence respectively after radical gastrectomy for gastric cancer. The aim of this study was to validate the two models in independent patient cohorts, and to evaluate which factors may explain differences in prognosis between Korean and Italian patients with gastric cancer.

METHODS

Patients who underwent radical gastrectomy for gastric cancer between January 2000 and December 2004 at Seoul National University Hospital and at eight centres in Italy were included. Discrimination of the models was tested with receiver operating characteristic (ROC) curves and calculation of area under the curve (AUC). Calibration was evaluated by plotting actual survival probability against predicted survival probability for the Korean nomogram, and actual against predicted risk of recurrence for the Italian score.

RESULTS

Some 2867 and 940 patients from Korea and Italy respectively were included. The Korean nomogram achieved good discrimination in the Italian cohort (AUC 0·80, 95 per cent c.i. 0·77 to 0·83), and the Italian model performed well in the Korean cohort (AUC 0·87, 0·85 to 0·89). The Korean nomogram also achieved good calibration, but this was not seen for the Italian model. Multivariable analyses confirmed that Italian ethnicity was an independent risk factor for cancer recurrence (odds ratio (OR) 1·72, 1·31 to 2·25; P < 0·001), but not for overall survival (OR 1·20, 0·95 to 1·53; P = 0·130).

CONCLUSION

Both prognostic models performed fairly well in independent patient cohorts. Differences in recurrence rates of gastric cancer may be partially explained by ethnicity.

摘要

背景

韩国和意大利已经开发出了预测胃癌根治术后总生存和癌症复发的预后模型。本研究的目的是在独立的患者队列中验证这两个模型,并评估哪些因素可能解释韩国和意大利胃癌患者之间预后的差异。

方法

纳入 2000 年 1 月至 2004 年 12 月期间在首尔国立大学医院和意大利 8 个中心接受胃癌根治术的患者。通过接收者操作特征(ROC)曲线和计算曲线下面积(AUC)来测试模型的区分度。通过绘制韩国列线图的实际生存概率与预测生存概率图,以及意大利评分的实际与预测复发风险图来评估校准情况。

结果

分别纳入了来自韩国和意大利的 2867 例和 940 例患者。韩国列线图在意大利队列中具有良好的区分度(AUC 0·80,95%置信区间 0·77 至 0·83),意大利模型在韩国队列中表现良好(AUC 0·87,0·85 至 0·89)。韩国列线图也具有良好的校准,但意大利模型则不然。多变量分析证实,意大利裔是癌症复发的独立危险因素(比值比(OR)1·72,1·31 至 2·25;P < 0·001),但不是总生存的独立危险因素(OR 1·20,0·95 至 1·53;P = 0·130)。

结论

这两个预后模型在独立的患者队列中表现相当。胃癌复发率的差异部分可以用种族来解释。

相似文献

1
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.验证两种用于预测胃癌根治术后复发和生存的预后模型。
Br J Surg. 2017 Aug;104(9):1235-1243. doi: 10.1002/bjs.10551. Epub 2017 May 10.
2
Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.用于预测胃癌行 d2 胃切除术患者长期生存的列线图
J Clin Oncol. 2012 Nov 1;30(31):3834-40. doi: 10.1200/JCO.2012.41.8343. Epub 2012 Sep 24.
3
Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.预测胃癌根治性胃切除术后的腹膜复发:基于韩国数据库验证预测模型(PERI-Gastric 1 和 PERI-Gastric 2)。
Eur J Surg Oncol. 2024 Jun;50(6):108359. doi: 10.1016/j.ejso.2024.108359. Epub 2024 Apr 19.
4
Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.预测胃癌根治性切除术后的复发:意大利胃癌研究组(GIRCG)预后评分系统的外部验证
Eur J Surg Oncol. 2016 Jan;42(1):123-31. doi: 10.1016/j.ejso.2015.08.164. Epub 2015 Sep 3.
5
Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer.腹腔镜辅助与开腹全胃切除术治疗早期胃癌的疗效比较。
Br J Surg. 2015 Nov;102(12):1500-5. doi: 10.1002/bjs.9902. Epub 2015 Sep 23.
6
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study.非贲门胃癌根治术后复发预测评分的外部验证:随访研究结果。
J Am Coll Surg. 2015 Aug;221(2):280-90. doi: 10.1016/j.jamcollsurg.2015.03.042. Epub 2015 Mar 31.
7
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.二线治疗晚期胃癌患者生存概率的估计:胃癌生存诺莫图。
Oncology. 2018;95(6):344-352. doi: 10.1159/000491753. Epub 2018 Aug 21.
8
The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.胃癌根治性手术后检测有症状或无症状复发的预后价值。
J Surg Res. 2013 Mar;180(1):e1-9. doi: 10.1016/j.jss.2012.03.035. Epub 2012 Apr 11.
9
Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer.代谢综合征对胃癌根治术后肿瘤学结局的影响。
Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):372-8. doi: 10.1016/j.clinre.2013.11.009. Epub 2014 Jan 31.
10
Nomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy.基于全身炎症反应标志物的列线图预测可切除胃癌患者D2胃切除术后的生存情况。
Oncotarget. 2016 Jun 21;7(25):37556-37565. doi: 10.18632/oncotarget.8788.

引用本文的文献

1
Machine Learning Prediction of Early Recurrence in Gastric Cancer: A Nationwide Real-World Study.机器学习预测胃癌早期复发:一项全国性真实世界研究。
Ann Surg Oncol. 2025 Apr;32(4):2637-2650. doi: 10.1245/s10434-024-16701-y. Epub 2024 Dec 30.
2
External Validation of a Nomogram Developed for Predicting Overall Survival in Gastric Cancer Patients with Insufficient Number of Examined Lymph Nodes.用于预测检查淋巴结数量不足的胃癌患者总生存期的列线图的外部验证
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):137-144. doi: 10.14744/SEMB.2021.47587. eCollection 2022.
3
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial.
胃切除术(ADiGe)中腹部引流的效用:一项多中心非劣效性随机试验的研究方案。
Trials. 2021 Feb 17;22(1):152. doi: 10.1186/s13063-021-05102-1.
4
Comparison of Conventional Statistical Methods with Machine Learning in Medicine: Diagnosis, Drug Development, and Treatment.医学中传统统计方法与机器学习的比较:诊断、药物研发与治疗
Medicina (Kaunas). 2020 Sep 8;56(9):455. doi: 10.3390/medicina56090455.
5
Development and validation of an artificial neural network prognostic model after gastrectomy for gastric carcinoma: An international multicenter cohort study.胃癌术后人工神经网络预后模型的建立和验证:一项国际多中心队列研究。
Cancer Med. 2020 Sep;9(17):6205-6215. doi: 10.1002/cam4.3245. Epub 2020 Jul 15.
6
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer.建立并验证一个预测胃癌患者总生存期的术前列线图。
Cancer Med. 2020 Aug;9(16):5708-5718. doi: 10.1002/cam4.3225. Epub 2020 Jun 26.
7
Investigation of analgesic dose of nalbuphine combined with remifentanil after radical gastrectomy.根治性胃切除术后纳布啡联合瑞芬太尼镇痛剂量的研究
Exp Ther Med. 2019 Sep;18(3):1633-1638. doi: 10.3892/etm.2019.7715. Epub 2019 Jun 28.
8
Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter Study.增强恢复方案的依从性与胃癌择期手术治疗结局的相关性。一项基于西方人群的前瞻性多中心研究结果。
World J Surg. 2019 Oct;43(10):2490-2498. doi: 10.1007/s00268-019-05068-x.